Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-02

Clinical Trial Update: Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chlorogenic acid in patients with impaired glucose tolerance has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorogenic acid (chlorogenic acid)

Snippet

Sponsor: University of Guadalajara | Conditions: Impaired Glucose Tolerance | Phase 2 | Status: COMPLETED | Results posted: 2019-08-02